- Visibility 7 Views
- Downloads 0 Downloads
- DOI 10.18231/j.ijpo.2020.090
-
CrossMark
- Citation
Study of orbital tumors in a tertiary care eye hospital
- Author Details:
-
M Tulasi Priya *
-
Naval Kishore
Introduction
The eye is not only an organ of vision but also an index of beauty in the human race.[1] The volume of the orbit is small and confined by bony walls on all sides except anteriorly. Within this space is a juxtaposition of numerous structures that subserve visual as well as extraorbital functions.[2]
The bony orbit is the smallest unit and can be defined as an enclosure bordered by bony structures and a space that contains all tissues and organs that contribute to the function of the eye. Tumors of the orbit arise primarily from soft tissues and bones.[3]
Tumors of the orbit are rare diseases in ophthalmic pathology-3.5 to 4%.[4], [5] All anatomic structures of the orbit can give rise to neoplasm.[6] Majority originate between the bony orbital wall and the extraocular muscle cone.[7] Orbital tumors are classified into primary and secondary orbital tumors.[2] Primary orbital tumors include benign and malignant neoplasms. The direct extension from contiguous anatomical structures, lymphoproliferative disorders, and hematogenous metastasis result in secondary orbital invasion.[6] Also the proximity of the paranasal sinuses may lead to the secondary spread of sinus neoplasia and infections or inflammation into the confines of the orbit.[3]
Most common pediatric tumors are Dermoid cysts, Capillary hemangiomas and Rhabdomyosarcoma.[8], [9] Most common adult tumors are Lymphoid tumors, Cavernous hemangiomas and Meningiomas.[5], [6] The major presenting symptom is proptosis resulting from the mass effect. Changes in visual acuity or field of vision, diplopia, extraocular motility disturbances or pupillary abnormalities can result from invasion or compression of intraorbital contents secondary to solid tumor. Lid dysfunction and lagophthalmos or lacrimal gland dysfunction can result in exposure keratopathy,keratitis and thinning of cornea.[5]
Orbital tumors constitute a heterogenous array of lesions and as such pose numerous challenges in terms of diagnosis, imaging and management.[10] They call for a closer attention due to its specific anatomic structure and location. Orbital tumors generally require a multidisciplinary approach with cooperation of a number of medical specialities.[11]
Aims and Objectives
To analyse the histomorphological features of Orbital Tumors.
To compare the results of the present study with other studies in the literature.
Materials and Methods
The present study is a prospective and retrospective study done between December 2013 to September 2016. All surgically resected specimens of orbital tumors received by Department Of Pathology, Sarojini Devi eye hospital were included. Samples were obtained either through incisional or excisional biopsy. An informed consent was taken from all the study subjects. A total of 54 cases were taken up for the study.
Inclusion criteria
All ages.
Both sexes.
All benign and malignant tumors of orbit including primary and secondary tumors.
Lacrimal gland tumors.
Exclusion criteria
Intraocular tumors.
Infectious and inflammatory lesions of the orbit.
Eye lid tumors.
A detailed history taking followed by a detailed ocular examination was done. Routine blood investigations, Xray, MRI and CT scan were done wherever necessary. The lesions were approached as per their anatomical location, size, extent and suspected pathology. The surgically resected specimens were fixed in 10% formalin. Thorough gross examination of each mass for its size, shape and consistency was done.
4-5 sections of 1.2 mm thickness were taken from different areas of the specimen and processed in automatic tissue processor. Blocks were prepared with the help of leuckharts piece. The sections were stained by H&E in all the cases. Immunohistochemistry by different immune markers was done selectively. A histopathological diagnosis thus made was entered in the proforma.
Results
For the period Dec 2013 to Sep 2016: 54 patients with orbital tumors.
Sex ratio: M/F-1.5.
Age ratio: Adult / children – 1.5.
Majority of the patients presented with mass and proptosis.
70.3% cases were benign and 29.6% cases were malignant.
Majority of childhood tumors were dermoid cysts.
6 Out of 54 cases were secondaries.
12 Out of 54 cases were lacrimal gland lesions.
4 Out of 54 cases were meningiomas.
Primary Orbital Tumors | Neural Tumors |
Choristomas | Amputation neuroma |
Epidermoid cyst | Neurofibromas |
Dermoid cyst | Neurilemmoma |
Teratoma | Juvenile pilocystic astrocytoma |
Ectopic lacrimal gland | Peripheral primitive neuroectodermal tumors (PNETs) |
Hamartomas | Miscellaneous Tumors |
Phakomatoses | Meningioma |
Hemangioma | Nonchromaffin paraganglioma |
1. Capillary hemangioma | Granular cell tumor |
2. Cavernous hemangioma | Alveolar soft-part sarcoma |
Arteriovenous communication | Malignant melanoma |
Telangiectasia | Endodermal sinus tumor |
Lymphangioma | |
Mesenchymal Tumors | Epithelial Cysts and Neoplasms of Lacrimal Gland |
Vascular | Lacrimal ductal cysts |
1. Hemangiopericytoma | Benign mixed tumor |
2. Glomus tumor | Malignant mixed tumor |
3. Hemangiosarcoma | Adenoid cystic carcinoma |
4. Kaposi’s sarcoma | Other types of carcinoma |
Fatty | Reticuloendothelial System, Lymphatic System, and Myeloid System |
1. Lipoma | Langerhans’ granulomatoses (histiocytosis X) |
2. Liposarcoma | Eosinophilic granuloma |
Fibrous | Hand–Schüller–Christian disease |
1. Reactive fibrous proliferations | Letterer–Siwe disease |
• Nodular fasciitis | Juvenile xanthogranuloma |
• Juvenile fibromatosis | Sinus histiocytosis |
2. Neoplastic fibrous proliferations | Inflammatory pseudotumor |
• Fibrous histiocytoma | Malignant lymphoma |
• Fibroma and fibrosarcoma | Leukemia |
• Solitary fibrous tumor | Multiple myeloma |
3. Giant cell angiofibroma | Monoclonal and polyclonal gammopathies |
Muscle | Secondary Orbital Tumors |
1. Leiomyoma and leiomyosarcoma | Direct Extension |
2. Mesectodermal leiomyosarcoma | Metastatic |
3. Rhabdomyoma | |
4. Rhabdomyosarcoma | |
Cartilage | |
1. Chondroma and chondrosarcoma | |
Bone | |
1. Aneurysmal bone cyst | |
2. Fibrous dysplasia | |
3. Giant cell tumor | |
4. Juvenile fibromatosis | |
5. Leontiasis ossea | |
Osteitis Fibrosa Cystica | |
Osteopetrosis | |
Paget’s disease | |
Osteoma and osteogenic sarcoma |
S. No. | Sex | Total no. of tumors | No. of benign tumors | No. of malignant tumors |
1. | Males | 33(61%) | 21 | 12 |
2. | Females | 21 (39%) | 17 | 4 |
Total | 54 cases | 38 | 16 |
S. No. | Age | Benign Tumors | Malignant Tumors |
1. | 1-10 | 11 | 1 |
2. | 11-20 | 10 | 2 |
3. | 21-30 | 3 | 3 |
4. | 31-40 | 4 | 1 |
5. | 41-50 | 7 | 4 |
6. | 51-60 | 3 | 3 |
7. | 61-70 | 0 | 2 |
S. No. | Symptoms | Percentage |
1. | Swelling | 57.4% |
2. | Axial Proptosis | 35% |
3. | Eccentric Proptosis | 7.4% |
4. | Others | 12.9% |

Benign | No. of cases | Malignant | No. of cases |
Dermoid Cyst | 18 | Secondaries | 06 |
Hemangioma | 05 | Lymphoma | 05 |
Pleomorphic Adenoma of Lacrimal Gland | 04 | Adenoid Cystic Carcinoma of Lacrimal Gland | 03 |
Schwannoma | 02 | Embryonal Rhabdomyosarcoma | 02 |
Lacrimal Ductal Cyst | 03 | ||
Epidermoid Cyst | 01 | ||
Solitary Fibrous Tumor | 01 | ||
Meningioma | 04 | ||
Total | 38 | Total | 16 |
Benign | No. of cases | Malignant | No. of cases |
Dermoid cyst | 17 | RMS | 2 |
Capillary hemangioma | 03 | Retinoblastoma orbital extension | 1 |
Meningioma | 01 | ||
Total | 21 | Total | 3 |

S. No. | Histopathological diagnosis | No. of cases |
1. | Lacrimal ductal cyst | 03 |
2. | Pleomorphic adenoma | 04 |
3. | Adenoid cystic carcinoma | 03 |
4. | DLBCL | 02 |
Total | 12 |
S.No. | Site | No.of cases | IHC | Histopathological Diagnosis |
1. | Lacrimal gland | 2 cases | (CD 20,CD 79a)-positive ALK-1-negative | DLBCL |
2. | Extraconal space | 3 cases | 2 cases-CD 20 positive And BCL2 positive in germinal center | Follicular lymphoma-Low grade |
3. | - | - | 1 Case-(CD 20,CD 79a)-positive, ALK-1-negative | DLBCL |
4. | Total | 5 cases |

Study | No. of patients studied | Year studied | Duration of study |
Present study | 54 | 2013 to 2016 | 3 years |
Tanushree et al, 2015 | 48 | 2010 to 2014 | 4 years |
Boriana et al, 2007 | 28 | 2001 to 2005 | 4 years |
Radha et al, 2005 | 24 | 2003 to 2005 | 2 years |
Jasna et al, 2004 | 24 | 1998 to 2003 | 5 years |
Demirci et al, 2002 | 200 | - | 25 years |
Studies | Age (maximum no. of patients) | Sex (M) | Sex (F) |
Present study | 1st,2 nd and 5 th decades | 61% | 39% |
Tanushree et al, 2015 | 2nd and 3rd decades | 45.8% | 54.1% |
Boriana et al, 2007 | 6 th and 7th decades | 60% | 40% |
Radha et al, 2005 | 5th decade | 62.5% | 37.5% |
Jasna et al, 2004 | 1st and 7th | 60% | 40% |
S. No | Clinical symptoms | Present study | Tanushree et al, 2015 | Radha et al, 2005 | Demirci et al, 2002 |
1. | Swelling or mass | 57.4% | 27% | 62.5% | 26% |
2. | Proptosis of eye | 42.5% Axial -35% Eccentric -7.4% | 63% Axial -32% Eccentric -11% | 83.3% | 18% |
3. | Other –symptoms | Defective vision, pupillary abnormalities and optic atrophy-12.9% | Defective vision (33.3%) restricted mobility(25), Ptosis (8.3%) | Pain-15% |
Histopathological diagnosis | Present study | Tanushree et al, 2015 | Boraina et al, 2007 | Radha et al, 2005 | Shields et al, 2002 |
Dermoid cysts | 33.3% | 33% | 12.5% | 4.2% | 2% |
Lacrimal gland tumors | 16% | 10 | - | 8.4% | 9% |
Secondaries | 11% | 4% | 44% | 4.2% | 11% |
Lymphomas | 9.2% | 4% | 16% | 33.3% | 11% |
Cavernous hemangiomas | 9.2% | 10% | 4% | 16.6%. | 6% |
Meningiomas | 7.4% | 6% | - | - | 4% |
S.No. | Study | Percentage of lacrimal gland tumors with epithelial origin | Percentage of lacrimal gland tumors with non epithelial origin |
1. | Present study | 77.7% | 22.3% |
2. | Tanushree et al, 2015 | 100% | - |
3. | Radha et al, 2005 | 100% | - |
4. | Jasna et al, 2004 | 100% | - |
S. No. | Study | No.of cases | Histopathological diagnosis | Age group |
1. | Present study | 9.2% | 3 cases –DLBCL 2 cases-Follicular lymphoma low grade | 47-62 years |
2. | Tanushree et al, 2015 | 4% | Non Hodgkin lymphoma | Older age group |
3. | Boriana et al, 2007 | 3.5% | Non Hodgkin lymphoma | - |
4. | Radha et al, 2005 | 20.8% | 80% were MALTOMAS | 54-72 years |
5. | Jasna et al, 2004 | 16% | All typed as Diffuse B cell phenotype | 71-80 years |
6. | Bastola et al, 2013 | 37.5% | Non Hodgkin lymphoma | - |
S. No. | Reporting of pattern | Proportion follicular |
1. | Follicular | >75% |
2. | Follicular and diffuse | 25-75% |
3. | Focally follicular | <25% |
4. | Diffuse | 0% |
S. No. | Study | No. of cases of Direct extension | No. of cases of Metastatic deposit | Total no. of cases and percentage | Age group |
1. | Present study | 5 | 1 | 6 cases (11%) | 5 cases-5th to 7th decades |
2 | Boriana et al, 2007 | 9 | 2 | 11 cases (44%) | - |
3. | Tanushree et al, 2015 | 1 | 1 | 2 cases (4%) | - |
4. | Radha et al, 2005 | 1 | - | 1 case (4.2%) | 8th decade |
5. | Jasna et al, 2004 | 3 | - | 3 cases (12%) | 2 cases-8th decade1 case-7th decade |
6. | Shields et al,2004 | - | - | 142 cases (11%) | Older age group |
















Discussion
Most common pediatric tumors are Dermoid cysts, Capillary hemangiomas and RMS.[8], [9] Most common adult tumors are Lymphoid tumors, Cavernous hemangiomas and Meningiomas.[5], [6] Most lymphomas are low-grade B-cell lymphoma, with extranodal marginal zone lymphoma (ENMZL) as the most common type.[12]
In the present study out of 54 cases, benign tumors (70.3%) were found to be common than malignant tumors (29.6%). In Tanushree et al 2015[13] out of 48 patients, benign tumors accounted for 90% and malignant 10% of the cases. In Radha et al 2005[14] out of 24 patients studied 70.8% accounted for benign tumors and 29.2% malignant tumors. Thus correlating with Tanushree et al, Radha et al and Jasna et al. But in Boriana et al 2007[15] malignant tumors were found to more common.



Among the benign tumors, dermoid cyst was found to be most common(33.3%). This correlated with Tanushree et al.[13] Other studies show varied percentages. 88% of the dermoid cysts were seen in 1st and 2nd decade. Dermoid cyst is the most common orbital cystic lesion in children. It accounts for over 40% of all orbital lesions of childhood and for 89% of all orbital cystic lesions of childhood that come to the biopsy or surgical removal.[16]
In the present study, maximum number of patients were in 1st, 2nd and 5th decades. A total of 24 (44.4%) orbital tumors were seen in 1st and 2nd decades. Of these, 21 cases (87.5%) were benign and 3 cases (12.5%) were malignant. Thus benign tumors were the majority in the first and second decades. Of the benign tumors, dermoid cysts predominated. In the present study, among the malignant tumors in childhood age group, 2 cases of embryonal rhabdomyosarcoma were diagnosed based on the morphology and 1 case of secondary with direct extension from ocular retinoblastoma. Of the 2 cases of RMS, 1 case was seen in 13 year old male patient and other case was seen in 15 year old male child. Both cases presented with proptosis.
In Jasna et al 2004[17] and Saha somnath et al 2002[1] also, there were 2 cases of rhabdomyosarcoma. In Saha somnath et al 2002[1] pediatric tumors were rare (22.6%). Most of the orbital tumors of childhood are distinct from the tumors that occur in adults. The most common orbital malignancy in childhood is Rhabdomyosarcoma.[18] However, the majority of pediatric orbital tumors are benign and usually include developmental cysts, capillary hemangioma and hamartoma.[19]
Rhabdomyosarcoma is malignant soft tissue sarcoma that recapitulates the phenotypic and biological features of skeletal muscle.[20] RMS is the most common soft tissue sarcoma in children.[21], [22] About 42% of patients with orbital rhabdomyosarcoma are aged 5–9 years; they present with proptosis or dysconjugate gaze.[23] Embryonal rhabdomyosarcomas constitute the most common subtype of rhabdomyosarcoma of the orbit by far. A special subtype of embryonal rhabdomyosarcoma is botryoid rhabdomyosarcoma (involving the conjunctiva).[24] Overall 5-year survival rates have improved to more than 80% with the combined use of surgery, radiation therapy, and chemotherapy in patients with localized orbital disease.[23], [24], [25]
In this study, lacrimal gland lesions accounted for 12 cases (22.2%). Out of 12 cases, 3 cases were lacrimal ductal cyst, 4 cases pleomorphic adenoma, 3 cases adenoid cystic carcinoma and 2 cases non hodgkins lymphoma. In Tanushree et al[13] of 5 cases,4 cases were pleomorphic adenoma and 1 case of adenoid cystic carcinoma. In Radha et al[14] out of 2 cases, 1 case of pleomorphic adenoma and 1 case of adenoid cystic carcinoma. In Jasna et al 2004 out of 25 cases, 2 cases were pleomorphic adenoma. Thus all were of epithelial origin in Tanushree et al, Radha et al and Jasna et al. Lacrimal gland lesions represent 5–25% of orbital tumors, and the proportion in the literature that are epithelial in origin, range from 23% to 70% of biopsied cases.[26], [27], [28], [29]
In the present study, among the lacrimal gland tumors, benign tumors were 44.4% and malignant 55.5%. Thus malignant tumors were slightly common than benign tumors. The age group ranged from 28 to 62 years. Thus in Radha et al[14] among the lacrimal gland tumors 50% benign and 50% were malignant.us the present study shows similar observation as seen in Radha et al study. In Tanushree et al [13]mong the lacrimal gland tumors, 80% were benign and 20% were malignant. Thus, benign tumors were in much greater number in Tanushree et al. In Jasna et al, only benign tumors were seen.
Shields et al [17] in 2004 concluded that approximately 55% are benign and 45% are malignant. In Perez et al,[30] out of 18 cases, 66.7% were Adenoid cystic carcinoma, 27.8% were pleomorphic adenoma and 5.5% were carcinoma ex pleomorphic adenoma. This indicates a different distribution of benign and malignant epithelial lesions with a higher rate of malignancy.
In the present study, Pleomorphic adenoma was found to be most common benign epithelial tumor. Similar observation was found in Tanushree et al,[13] Radha et al,[14] Jasna et al.[18] Although pleomorphic adenomas are histologically benign, incomplete excision will lead to recurrences and even malignant transformation. Hence, when suspected, lateral orbitotomy is mandatory and entire tumor must be excised enbloc.[31]
In the present study,out of 9 cases of lacrimal gland tumors, there were 3 cases of adenoid cystic carcinoma. It was found to be most common malignant epithelial tumor. In Radha et al.[14] Whereas in Tanushree et al,[13] mucoepidermoid was found to be common. In Jasna et al,[18] there were no malignant cases.
In the present study, all the three cases of adenoid cystic carcinoma were seen in 3rd decade (21-30). Thus it is seen in young adults.Whereas in Radha et al[14] it was seen in older age group (6th decade). Lacrimal gland ACC generally affects young to middle aged patients (range 6.5–79 years).[3]
The outcome for patients with ACC in the lacrimal gland is reportedly poorer than that with ACC in the salivary gland.[32] Thorough histologic examination of ACC in order to detect any solid or dedifferentiated component and evaluation of the margins as well as perineural invasion are important. Major cause of death is intracranial spread hastened by perineural invasion. Treatment is exenteration and post- operative radiotherapy.[14]
In the present study, out of 9 cases of lacrimal gland tumors, 2 cases (22%) were non epithelial. Of the non epithelial tumors, all were non hodgkins lymphomas. After running a panel of markers, all were confirmed as Diffuse Large Bcell Lymphoma. Thus DLBCL was found to be most common type of lymphoma among lacrimal gland tumors. In Sjo LD, et al[33] out of 15 primary lacrimal sac lymphomas, five cases (33%) were diffuse large B cell lymphomas.
The Ocular Adnexal Lymphoma (OAL) represents malignant lymphoid neoplasms, which can develop as primary or secondary tumor manifestations. Lymphoma localized in the ocular region (eyelid, conjunctiva, lacrimal drainage system, orbit, and intraocular) is one of the most common orbital malignancies.[34], [17] 78% of lymphomas involving the ocular adnexa are primary, whereas 22% are secondary.[12] OAL is primarily a disease of older adults (peak age 65 years) with a slight female preponderance.[33] The deep orbital tissue is considered as true extranodal/nonfunctional mucosa-associated tissue (ENMZL) whereas the lacrimal gland, the conjunctiva, and the lacrimal sac are considered as functional mucosa-associated tissues.[35] Mucosa associated lymphoid tissue lymphoma (MALT) is therefore not synonymous with ENMZL and is characterized by mucosal location and lymphoepithelial lesions. Lymphoma arising in the lacrimal sac was surprisingly predominantly DLBCL.[33]
FL are BCL-2 and CD10 positive in 85% of cases: BCL-2 is quite specific versus germinal centers. CD10 is quite specific versus other small B lymphomas. They also stain positive for BCL-6 and show expansion of follicular dendritic cell networks staining positive for CD21, CD23, and CD35. They are graded as low and high grade.
LOW GRADE -0 to 15 centroblasts per high power field.
HIGH GRADE –more than 15 centroblasts per high power field.[36]
In the present study, there were 6 cases (11%) of secondaries. Of these, 5 cases were of direct extension and 1 case of metastatic deposit. Of the 5 cases of direct extension, there was 1 case each of sinonasal adenocarcinoma extending from paranasal sinus, 1 case of squamous cell carcinoma extending from conjunctiva, 1 case of retinoblastoma extending from eye and 2 cases of choroidal malignant melanoma. Metastatic deposit was from breast carcinoma.
In the present study, out of 54 cases, one case of solitary fibrous tumor is seen on histopathology. IHC revealed CD 34 positivity. Hemangiopericytomas and Solitary fibrous tumors are uncommon neoplasms found in orbit. Local recurrences of SFT are possible and usually follow an incomplete initial excision.[37] In Furusato et al 2010,[36] Forty-one fibroblastic orbital tumors, originally diagnosed as hemangiopericytomas (n = 16), fibrous histiocytomas (n = 9), mixed tumors (hemangiopericytomas/fibrous histiocytoma) (n = 14), and giant cell angiofibromas of orbit (n = 2) between 1970 and 2009, were retrieved, the Ophthalmic Registry, at the Armed Forces Institute of Pathology. Slides and clinical records were reviewed, analyzed, and compared. IHC was performed for CD34, CD99, Bcl-2, Ki-67, and p53 and all cases were reclassified as solitary fibrous tumor (41/41).
In Furusato et al 2010,[36] overlapping features with soft tissue giant cell fibroblastoma were observed. IHC revealed positivity for CD34 in all cases (100%), p53 in 85%, CD99 in 67.5%, and Bcl-2 in 47.5%. Although Ki-67 labeling was seen in all cases, it ranged from less than 1% in 54.3% of cases to 5% to 10% in 20% of cases.
In the present study, 4 cases(7.4%) of Meningioma are seen and 2 cases(3.2%) of Schwannomas (confirmed on IHC–S100 positive). All the patients presented with axial proptosis and other findings such as diminution of vision, defective pupillary reaction and optic atrophy. Of these, 1 case was seen in 1st decade and 4th decade each and 2 cases seen in 5th decade. All the cases presented as intraconal mass. Of these, 3 cases diagnosed as Meningothelial Meningioma, WHO grade 1 and 1 case as Angiomatous Meningioma WHO grade 1. In Tanushree et al 2015,[13] there were 3 cases (6%) of meningioma and 2 cases (4%) of schwannoma. All the patients had axial proptosis and other findings such as diminution of vision, defective pupillary reaction and optic atrophy. Thus correlating with Tanushree et al study. In Jasna et al 2004,[18] there were 4 cases(16%) of meningioma. In Saha Somnath et al 2002,[1] there was 1 case (3%) of schwannoma.
Meningiomas can arise from the optic nerve or extend into the orbit from adjacent structures.[38] The age at presentation of patients with optic nerve meningiomas is typically younger than for intracranial meningiomas.[39] A number of meningioma subtypes have been proposed through the years, and the current (2016) World Health Organization (WHO) classification includes 15 named entities.[40]
Intraorbital meningiomas were most frequently of the meningothelial or transitional subtypes and were WHO grade 1. Significant changes that affect tumor grade are further classified (1) meningiomas showing central nervous system invasion as grade II rather than grade III (2) meningiomas with 4 or more mitotic figures per 10 high-power fields (HPFs) as grade II (3) Clear Cell and Chordoid Meningiomas as grade II (4) Papillary and Rhabdoid Meningiomas as grade III, and (5) tumors with 20 or more mitotic figures per 10 HPFs as grade III.[41]
In Deepali Jain et al 2010,[42] a total of 51 intraorbital meningiomas were reviewed. Meningothelial type was most common (25 of 51 tumors; 49%). Most (47 of 51; 92%) of the tumors were WHO grade I. They concluded that Intraorbital meningiomas were most frequently of the meningothelial or transitional subtypes and were WHO grade I.
Schwannomas are benign peripheral nerve sheath tumors derived from Schwann cells. Nuclear atypia with hyperchromatic pleomorphic nuclei can be observed in Ancient Schwannoma.[43] Mitotic figures with counts of 6 mitoses per 10 HPF can be observed. True malignant change of Schwannoma is very rare.
Source of Funding
None.
Conflict of Interest
None.
References
- Heegaard, Steffen, Grossniklaus, Hans. . Eye Pathology, An Illustrated Guide 2015. [Google Scholar]
- Balabanov Ch, B Parashkevova, S Murgova, I Iordanov. Tumors of the eye and adnexa. Bulgarian Rev Ophthalmol 2005. [Google Scholar]
- Stuart H. Goldberg, William A. Cantore. Tumors of the orbit. Curr Opin Ophthalmol 1997. [Google Scholar]
- J Rootman. Diseases of the orbit. Frequency and Differential Diagnosis 1988. [Google Scholar]
- Somnath Saha, Padmini Vedula Saha, Sarbani Chattopadhyay. Orbital and Paraorbital Tumors - Clinicopathological Profile and Surgical Management. 2002. [Google Scholar]
- Myron Yanoff, Joseph Sassani. The orbit including the lacrimal gland and lacrimal drainage system. Ocular Pathology 2014. [Google Scholar]
- Robert A. Weisman, Donald Kikkawa, Kristen S. Moe, J. David Osguthorpe. Orbital tumors. Otolaryngol Clin North Am 2001. [Google Scholar]
- H Bouguila, I Malek, L Nacef, S Marrakchi, F Dagfous, S Ayed. Intraorbital dermoid cyst. Apropos of a case. J Fr Ophtalmol 1999. [Google Scholar]
- B Gloor, A Kalman. Neoplasticspace-occupying lesions of the orbit.I. Review; hemangioma, lymphangiomaand embryonal rhabdomyosarcoma. Klin Monatsbl Augenheilkd 1992. [Google Scholar]
- J J Dutton, S F Byrne, A D Proia. . Diagnostic Atlas of Orbital Diseases 2000. [Google Scholar]
- I W Mclean, M N Burnier, L E Zimerman, F A Jakobiec. Tumors of the orbit. Atlas of tumor pathology of eye and ocular adnexa 1994. [Google Scholar]
- J A Ferry. Orbital space-occupying lesions in Denmark 1974-1997. Acta Ophthalmol Scand 2000. [Google Scholar]
- V Tanushree, H T Venkate Gowda, Uma Balakrishnan, I Amarkulkarn. Clinical and Histopathological Study of Orbital Tumors. Int J Curr Res 2015. [Google Scholar]
- J Radha, Ani Sreedhar. Orbital Tumors - A Clinico Pathological Study. 2005. [Google Scholar]
- Boriana Parashkevova, Chavdar Balabanov, Dessislava Stateva. Orbital Tumors-Clinical Cases Presentation. J IMAB - Annu Proc(Scientific Papers) 2007. [Google Scholar]
- Jerry A Shields, Carol L Shields. Orbital cysts of childhood—classification, clinical features, and management. Surv Ophthalmol 2004. [Google Scholar]
- Jerry A Shields, Carol L Shields, Richard Scartozzi. Survey of 1264 patients with orbital tumors and simulating lesions. Ophthalmol 2004. [Google Scholar]
- Jasna Talan-Hraniloviæ, Davor Tomas. 15th Ljudevit Jurak International Symposium On Comparative Pathology. 2004. [Google Scholar]
- Bienvenido V Castillo, Lawrence Kaufman. Pediatric tumors of the eye and orbit. Pediatr Clin N Am 2003. [Google Scholar]
- C D Fletcher, K K Unni, F Mertens, P Kleihues, L H Sobin. Pathology and genetics of tumours of soft tissue and bone. World Health Organization classification of tumours 2002. [Google Scholar]
- A P Stout. Rhabdomyosarcoma of the skeletal muscles. Ann Surg 1946. [Google Scholar]
- Carola A.S. Arndt, William M. Crist. Common Musculoskeletal Tumors of Childhood and Adolescence. New Engl J Med 1999. [Google Scholar]
- Roman Kodet, William A. Newton, Ala B. Hamoudi, Lina Asmar, Moody D. Wharam, Harold M. Maurer. Orbital rhabdomyosarcomas and related tumors in childhood: Relationship of morphology to prognosis—an intergroup rhabdomyosarcoma study. Med Pediatr Oncol 1997. [Google Scholar]
- E Polito. A Case of Primary Botryoid Conjunctival Rhabdomyosarcoma. Graefes Arch Clin Exp Ophthalmol 2006. [Google Scholar]
- Judith A. Punyko, Ann C. Mertens, K. Scott Baker, Kirsten K. Ness, Leslie L. Robison, James G. Gurney. Long-term survival probabilities for childhood rhabdomyosarcoma. Cancer 2005. [Google Scholar]
- C L Shields. Clinicopathologic review of 142 cases of lacrimal gland lesions. Ophthalmol 1989. [Google Scholar]
- J A Shields. Classification and incidence of space-occupying lesions of the orbit. A survey of 645biopsies. Arch Ophthalmol 1984. [Google Scholar]
- R E Kennedy. An evaluation of 820 orbital cases. Trans Am Ophthalmol Soc 1984. [Google Scholar]
- C Ni, P K Kuo, T P Dryja. Histopathological classification of 272 primary epithelial tumors of the lacrimal gland. Chin Med J (Engl) 1992. [Google Scholar]
- Danyel E. C. Perez, Fàbio R. Pires, Oslei P. Almeida, Luiz P. Kowalski. Epithelial Lacrimal Gland Tumors: A Clinicopathological Study of 18 Cases. Otolaryngol–Head Neck Surg 2006. [Google Scholar]
- R C Halli, S Mishra, Y K Kini. Modified Lateral Orbitotomy Approach: A Novel Technique In The Management Of Lacrimal Gland Tumors. J Craniofac Surg 2011. [Google Scholar]
- Q Zhou. Increased numbers of P63-positive/ CD117-positive cells in advanced adenoid cystic carcinoma give a poorer prognosis. Diagn Pathol 2012. [Google Scholar]
- L D Sjo, E Ralfkiaer, B R Juhl, J U Prause, T Kivelä, C Auw‐Haedrich. Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study. Br J Ophthalmol 2006. [Google Scholar]
- S Johansen. Orbital space-occupying lesions in Denmark 1974-1997. Acta Ophthalmol Scand 2000. [Google Scholar]
- Frederick A. Jakobiec. Ocular Adnexal Lymphoid Tumors: Progress in Need of Clarification. Am J Ophthalmol 2008. [Google Scholar]
- Emiko Furusato, Ives A. Valenzuela, Julie C. Fanburg-Smith, Aaron Auerbach, Bungo Furusato, J. Douglas Cameron. Orbital solitary fibrous tumor: encompassing terminology for hemangiopericytoma, giant cell angiofibroma, and fibrous histiocytoma of the orbit: reappraisal of 41 cases. Human Pathol 2011. [Google Scholar]
- F P Bernardini. Solitary fi brous tumor of the orbit: is it rare? Report of a case series and review of the literature. Ophthalmol 2003. [Google Scholar]
- Deepali Jain, Katayoon B. Ebrahimi, Neil R. Miller, Charles G. Eberhart. PhD Intraorbital Meningiomas A Pathologic Review Using Current World Health Organization Criteria. Arch Pathol Lab Med 2010. [Google Scholar]
- Jonathan J. Dutton. Optic nerve sheath meningiomas. Surv Ophthalmolo 1992. [Google Scholar]
- . WHO Classification of CNS Tumors, 4th Edition. . [Google Scholar]
- A Perry, D N Louis, B W Scheithauer, H Budka, Von Deimling, A Meningiomas, D N Louis, H Ohgaki, O D Wiestler, W K Cavenee. WHO Classification of Tumours of the Central Nervous System. World Health Organization Classification of Tumours 2007. [Google Scholar]
- W H Spencer, W.B. Saunders. . Ophthalmic Pathology: An Atlas and Textbook 1996. [Google Scholar]
- I Pecorella, J Toth, O Lukats. Ancient schwannoma of the orbit. Pathol 2012. [Google Scholar]